Beyond Air® Expands Leadership Team with the Appointment of Dr. Andrew Colin to Chief Medical Officer

Dec 01, 2021 8:00am EST

Beyond Air® Announces $30 Million of Committed Capital in Previously Reported Beyond Cancer™ Private Placement

Nov 18, 2021 4:05pm EST

Beyond Air® Reports Financial Results for the Second Quarter of Fiscal Year 2022

Nov 11, 2021 4:05pm EST

Beyond Air® Announces Formation of Beyond Cancer™, a New Private Company Dedicated to Oncology Utilizing Ultra-High Concentration Nitric Oxide to Treat Solid Tumors

Nov 04, 2021 7:30am EDT

Beyond Air® to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

Nov 02, 2021 8:00am EDT

Beyond Air® Schedules Second Fiscal Quarter 2022 Financial Results Conference Call and Webcast

Oct 25, 2021 8:00am EDT

Beyond Air® Reports Positive Interim Results for LungFit® GO Pilot Study Using High Concentration Inhaled Nitric Oxide Self-Administered, At-Home for Nontuberculous Mycobacterial Lung Disease

Oct 20, 2021 8:00am EDT

Beyond Air® Provides Global Regulatory Update for LungFit® PH

Sep 21, 2021 4:30pm EDT

Beyond Air® to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

Sep 14, 2021 7:30am EDT

Beyond Air® Announces CFO Transition

Aug 20, 2021 4:15pm EDT